Synthesize
发表于 2025-3-30 09:59:19
http://reply.papertrans.cn/39/3821/382002/382002_51.png
Injunction
发表于 2025-3-30 14:25:02
Anabolic Effects of MOPs: Cortical Drifting,A) approval was in 2017 for CD19-directed CAR-T cell therapy using tisagenlecleucel (tisa-cel) for the treatment of pediatric patients (up to age 25) with relapsed or refractory (R/R) B-acute lymphoblastic leukemia (B-ALL). That same year, CD19 CAR-T cell therapy with axicabtagene ciloleucel (axi-ce
自制
发表于 2025-3-30 18:30:10
http://reply.papertrans.cn/39/3821/382002/382002_53.png